Fusion of macrophages on an implant surface is associated with down-regulated expression of ligands for galectin-1 and -3 in the rat

Biomaterials

Volumn 19, Issue 19, 1998, Pages 1799-1806

  Smetana Jr , Karel ^a,b   Slavík, Jan ^c   Vancová, Eva ^a   Fischer, János ^d   Liu, Fu Tong ^e   Burchert, Maria ^f   Dong, Xin ^f   Gabius, Hans Joachim ^f  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^d INSTITUTE OF BIOCHEMISTRY   (Hungary)

^e LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biocompatibility; Foreign body reaction; Galectins; Granulomatous reaction; Lectins

Indexed keywords

AFFINITY CHROMATOGRAPHY; ANTIGEN-ANTIBODY REACTIONS; BIOCOMPATIBILITY; CELLS; MOLECULAR DYNAMICS; MONOCLONAL ANTIBODIES;

GALECTINS; LIGANDS;

IMPLANTS (SURGICAL);

ALPHA GALACTOSIDASE; CELLOPHANE; GALECTIN; GALECTIN 3; IMMUNOGLOBULIN G; LIGAND; MONOCLONAL ANTIBODY; PLANT LECTIN;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOCOMPATIBILITY; DOWN REGULATION; FOREIGN BODY REACTION; GRANULOMATOSIS; IMPLANTATION; MACROPHAGE; MALE; MULTINUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TOMATO; VISCUM ALBUM;

EID: 0032191469     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(98)00092-1     Document Type: Article

References (60)

1. [1] Smetana Jr K. Multinucleate foreign-body giant cell formation. Exp Mol Pathol 1987;47:258-65.
2. [2] Papadimitriou JM, VanBruggen I. Evidence that multinucleate giant cells are examples of mononuclear phagocytic differentiation. J Pathol 1986;148:149-57.
3. [3] Kreipe H, Radzun HJ, Rudolph P, Barth J, Hansmann M-L, Heidorn K, Parwaresh MR. Multinucleated giant cells generated in vitro. Terminally differentiated macrophages with down-regulated C-fms expression. Am J Pathol 1988;130:232-43.
4. [4] Galindo B, Lazdins T, Castillo R. Fusion of normal rabbit alveolar macrophages induced by supernatant from BCG-sensitised lymph node cells after elicitation by antigen. Infect Immun 1974;9: 212-6.
5. [5] Warfel AH, Hadden JW. Macrophages fusion factor elicited from BCG-sensitised lymphocytes. Am J Pathol 1978;93:758-66.
6. [6] Kao WJ, McNally AK, Hiltner A, Anderson JM. Role for interleukin-4 in foreign-body giant cell formation on poly(etherurethane urea) in vivo. J Biomed Mater Res 1995;29:1267-75.
7. [7] McNally AK, Anderson JM. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophages fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 1995; 147:1487-99.
8. [8] Sorimachi K, Akimoto K, Tsuru K, Ieiri T, Niwa A. The involvement of tumor necrosis factor in the multinucleation of macrophages. Cell Biol Int 1995;19:547-9.
9. [9] Weinberg JB, Hobbs MM, Misukonis MA. Recombinant human γ-interferon induces human monocytes polykaryon formation. Proc Natl Acad Sci USA 1984;81:4554-7.
10. [10] Lemaire I, Yang H, Lauzon W, Gendron N. M-CSF and GM-CSF promote alveolar macrophages differentiation into multinucleated giant cells with distinct phenotypes. J Leukocyte Biol 1996;60:509-18.
11. [11] Abe E, Miyaura C, Tanaka H, Shiina Y, Kuribyashi T, Suda S, Nishii Y, DeLuca HF, Suda T. 1,25-Dihydroxyvitamin D promotes fusion of mouse alveolar macrophages both by a direct mechanism and by spleen cell-mediated indirect mechanism. Proc Natl Acad Sci USA 1983;80:5583-7.
12. [12] Bardosi A, Dimitri T, Gabius H-J. Are glycoconjugates and their endogenous receptors involved in the fusion of mononuclear macrophages resulting in multinucleate giant cells. J Submicrosc Cytol Pathol 1989;21:229-38.
13. [13] McNally AK, DeFife K, Anderson JM. Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am J Pathol 1996;149:975-85.
14. [14] Smetana Jr K, Vacík J, Součková D, Krčová Z, Šulc J. The influence of hydrogel functional groups on cell behavior. J Biomed Mater Res 1990;24:463-70.
15. [15] Mariano M, Spector WG. The formation and properties of macrophages polykaryons (inflammatory giant cells). J Pathol 1974;113:1-19.
16. [16] Papadimitriou JM, Sforsina D, Papaelias L. Kinetics of multinucleate giant cell formation and their modification by various agents in foreign body reaction. Am J Pathol 1973;73: 349-64.
17. [17] Honma T, Hamasaki T. Ultrastructure of multinucleated giant cell apoptosis in foreign-body granuloma. Virchows Arch 1996; 428:165-76.
18. [18] Papadimitriou JM. Detection of macrophage receptors for heterologous IgG by scanning and transmission microscopy. J Pathol 1973;110:213-20.
19. [19] Mariano M, Nikitin T, Malucelli EE. Immunological and nonimmunological phagocytosis by inflammatory macrophages, epitheloid cells, and macrophages polykaryons from foreign-body granulomata. J Pathol 1975;120:151-60.
20. [20] Papadimitriou JM, Robertson TA, Walters MNI. An analysis of the phagocytic potential of multinucleate foreign-body giant cells. Am J Pathol 1975;78:343-58.
21. [21] Smetana Jr K. Identification of fibronectin in tissue implant interfaces. J Mater Sci Mater Med 1992;3:184-5.
22. [22] Gabius H-J. Animal lectins. Eur J Biochem 1997;243:543-76.
23. [23] Barondes SH, Cooper DNW, Gitt MA, Leffler H. Galectins. Structure and function of large family of animal lectins. J Biol Chem 1994;269:20807-10.
24. [24] Kasai K, Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J Biochem 1996;119:1-8.
25. [25] Gabius H-J, Vehmeyer K. Effect of microenvironment and cell-line type on carbohydrate-binding proteins of macrophages-like cells. Biochem Cell Biol 1988;66:1169-76.
26. [26] Rabinovich G, Castanga L, Landa C, Riera CM, Sotomayor C. Regulated expression of a 16-kd galectin-like protein in activated rat macrophages. J Leukocyte Biol 1996;59:363-70.
27. [27] Kajikawa T, Nakajima Y, Hirabayashi J, Kasai K, Yamazaki M. Release of cytotoxin by macrophages on treatment with human placenta lectin. Life Sci 1988;39:1177-81.
28. [28] Perillo, NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature 1995;378:736-9.
29. [29] Levi G, Tarrab-Hazdai R, Teichberg VI. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur J Immunol 1983;13:500-7.
30. [30] Offner H, Celnik B, Bringman TS, Casentini-Borocz D, Nedwin GE, Vandenbark AA. Recombinant human β-galactoside-binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol 1990;28:177-84.
31. [31] Truong MJ, Gruart V, Liu F-T, Prin L, Capron A, Capron M. Human eosinophils express functional IgE-binding molecules (Mac-2/εBP) of the S-type lectin family. Eur J Immunol 1993;23: 3230-5.
32. [32] Truong MJ, Gruart V, Kusnierz J-P, Papin J-P, Loiseau S, Capron A, Capron M. Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/εBP) of the S-type lectin family: role in IgE-dependent activation. J Exp Med 1993;177: 243-8.
33. [33] Woo HJ, Shaw LM, Meisser JM, Mercurio AM. The major non-integrin laminin-binding protein of macrophages is identical to carbohydrate-binding protein 35 (Mac-2). J Biochem 1990;265: 7097-9.
34. [34] Kawabara I, Liu F-T. Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 1996;156:3939-44.
35. ε RI) and activates mast cells. Biochemistry 1993;32:7644-49.
36. [36] Liu F-T, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson Jr WR. Expression and function of galectin-3, a β-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 1995;147:1016-28.
37. [37] Yang RY, Hsu DK, Liu F-T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 1996;93: 6737-42.
38. [38] Gabius H-J, Walzel H, Joshi SS, Kruip J, Kojima S, Gerke V, Kratzin H, Gabius S. The immunomodulatory β-galactoside-specific lectin from mistletoe: Partial sequence analysis, cell and tissue binding, and impact on intracellular biosignalling of monocytic leukemia cells. Anticancer Res 1992;12:669-76.
39. [39] Hajto T, Hostanska K, Frei K, Rordorf C, Gabius H-J. Increased secretion of tumor necrosis factor α, interleukin 1 and interleukin 6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1990;50:3322-6.
40. [40] Timoshenko AV, Gabius H-J. Efficient induction of superoxide release from human neutrophils by the galactoside-specific lectin from Viscum album. Biol Chem Hoppe-Seyler 1993;374:237-43.
41. [41] Janssen O, Scheffler A, Kabelitz D. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Arzneim-Forsch/Drug Res 1993;43:1221-7.
42. [42] Krugluger W, Koller M, Allmaier M, Boltz-Nitulescu G, Forster O. Ligation of N-acetylgalactosamine-containing structures on rat bone marrow cells enhances myeloid differentiation and murine granulocyte-macrophage colony-stimulating factor-induced proliferation. J Leukocyte Biol 1994;55:127-32.
43. [43] Krugluger W, Lucas T, Koller M, Boltz-Nitulescu G, Forster O. Soybean agglutinin binds a 160 kDa rat macrophages membrane glycoprotein and enhances cell differentiation and activation. Immunol Lett 1996;52:53-6.
44. [44] Dong X, Amselgruber W, Kaltner H, Gabius H-J, Sinowatz F. Affinity-purified antibodies against α-galactosyl residues from human serum: comparison of their binding in bovine testicular tissue with that of the Griffonia simplicifolia lectin (GSI-B4) and impact of labeling on epitope localization. Eur J Cell Biol 1995;68: 96-101.
45. [45] Dong X, André S, Hofer B, Kayser K, Gabius H-J. Disease type-associated increases of the plasma levels and ligand expression for natural α-or β-galactoside-binding immunoglobulin G subfractions in patients with lung cancer. Int J Oncol 1997;10: 709-19.
46. [46] Smetana Jr K, Gabius H-J, Vacík J, Jelínková M, Lukáš J. Mapping of endogenous lectins in macrophages colonizing an implanted polymer surface, effect of polymer structure. Biomaterials 1995;16:1149-52.
47. [47] Smetana Jr K, Jelínková M, Vacík J, Fischer J, Gabius H-J. Influence of the intraperitoneal injection of three types of hydrogel beads on expression of carbohydrate-binding sites in spleen macrophages. Biomaterials 1996;17:2335-41.
48. [48] Agrwal N, Sun Q, Wang S-Y, Wang JL. Carbohydrate-binding protein 35: properties of the recombinant polypeptide and the individuality of the domains. J Biol Chem 1993;268:14932-9.
49. [49] Gabius H-J. Influence of type of linkage and spacer on the interaction of β-galactoside-binding proteins with immobilized affinity ligands. Anal Biochem 1990;189:91-4.
50. [50] Gabius H-J, Wosgien B, Hendrys M, Bardosi A. Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody. Histochemistry 1991;95:269-77.
51. [51] Kayser K, Gabius H-J, Rahn W, Martin H, Hagemeyer O. Variations of binding of labelled tumor necrosis factor α, epidermal growth factor, ganglioside GM-1 and N-acetylglucosamine, galactoside-specific mistletoe lectin and lectin-specific antibodies in mesothelioma and metastatic adenocarcinoma of the pleura. Lung Cancer 1992;8:185-92.
52. [52] Brinck U, Bosbach R, Korabiowska M, Schauer A, Gabius H-J. Histochemical study of expression of lectin-reactive carbohydrate epitopes and glycoligand-binding sites in normal human appendix vermiformis, colonic mucosa, acute appendicitis and colonic mucosa. Histol Histopathol 1996;11:919-30.
53. [53] Smetana Jr K, Fischer J. Distribution of polylactosamines and vinculin in macrophages and foreign-body giant cells colonizing the cellophane implant surface. J Mater Sci Mater Med 1995;6:110-2.
54. [54] Danguy A, Gabius H-J. Lectins and neoglycoproteins-attractive molecules to study glycoconjugates and accessible sugar-binding sites of lower vertebrates histochemically. In: Gabius H-J, Gabius S, editors. Lectins and glycobiology. Berlin: Springer, 1993:241-50.
55. [55] Vidal-Vanaclocha F, Glaves D. In situ microdensitometry of neoglycoprotein staining: detection of tissue-site specific patterns of endogenous lectin expression. In: Gabius H-J, Gabius S, editors. Lectins and glycobiology. Berlin: Springer, 1993:251-9.
56. [56] Slavík J, Smetana K, Jr. Intracellular pH of macrophages and foreign body giant cells colonising an implant surface. J Immunofluorescence 1997;7 Suppl:203-5.
57. [57] Smetana K, Jr, Slavík J, Gabius H-J. Galectin-and C-type lectin-reactive asialofetuin induces an increase of cytoplasmic pH in implant-colonizing rat macrophages - an ex vivo study. Med Sci Monitor 1998;4:20-6.
58. [58] Sato S, Hughes RC. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J Biol Chem 1994;269:4424-30.
59. [59] Kasper M, Hughes RC. Immunocytochemical evidence for a modulation of galectin-3 (Mac-2), a carbohydrate binding protein, in pulmonary fibrosis. J Pathol 1996;179:309-16.
60. [60] Smetana Jr K. Cell biology of hydrogels. Biomaterials 1993;14: 1046-50.